Cara Therapeutics
Cara Therapeutics Logo
Logos are displayed for identification only. Logokit is not affiliated with, endorsed by, or sponsored by the companies shown.
About Cara Therapeutics
Cara Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing novel therapeutics for the treatment of pruritus and pain. Its lead product, KORSUVA (difelikefalin) injection, is approved for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis. The company is also developing oral difelikefalin for chronic pruritus with notalgia paresthetica. Cara Therapeutics has licensing agreements for the development and commercialization of its products in Japan, South Korea, and other regions. Founded in 2004, the company is headquartered in Stamford, Connecticut.
Address
400 Atlantic Street, Suite 500
Stamford, 06901
United States
Year founded
2004
Number of employees
100-200
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Add Cara Therapeutics logo and brand data to your app or website
Embed this logo using a simple HTML tag, or access structured brand data with a single call to our API.
<img src="https://img.logokit.com/caratherapeutics.com" />
Report inaccurate data
Request an update to help us keep the brand up-to-date.
